RAM
JAZZ icon

Readystate Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Readystate Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,251
Closed -$1.61M – 433
2025
Q3 		$1.61M Sell
12,251
-5,558
-31% -$667K 0.07% 162
2025
Q2 		$1.89M Sell
17,809
-5,060
-22% -$550K 0.06% 167
2025
Q1 		$2.84M Buy
22,869
+1,635
+8% +$213K 0.09% 259
2024
Q4 		$2.61M Buy
+21,234
New +$2.5M 0.08% 253

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Readystate Asset Management's JAZZ Position: Q4 2025 in Review

Readystate Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 12,251 shares — an estimated $1.61M sold.

Readystate Asset Management first reported a position in JAZZ in Q4 2024 and held it in 4 quarters. The position peaked at $2.84M in Q1 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • Readystate Asset Management reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Readystate Asset Management sold 12,251 Jazz Pharmaceuticals shares in Q4 2025, an estimated $1.61M.
  • Readystate Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Readystate Asset Management's Jazz Pharmaceuticals position peaked at $2.84M in Q1 2025.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.